Glass elevators and curving shapes in the atrium define Novartis's Cambridge building.
(John Tlumacki/Globe Staff/File 2005)
Novartis expects to grow more, but slower
Glass elevators and curving shapes in the atrium define Novartis's Cambridge building.
(John Tlumacki/Globe Staff/File 2005)
Six years after the Swiss drug giant Novartis AG built a major research center in Cambridge, the move is bearing fruit, corporate executives say. (Full article: 696 words)
This article is available in our archives:
Globe Subscribers
FREE for subscribers
Subscribers to the Boston Globe get unlimited access to our archives.
Not a subscriber?
Non-Subscribers
Purchase an electronic copy of the full article. Learn More
- $4.95 1 article
- $9.95 4 articles
- $25.95 Monthly
